Impact of Diabetes/Obesity on Adverse Outcomes from COVID-19
In this medfyle
Expert commentary by Marie E. McDonnell, MD
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ENDO Online 2020 and presented by:
Manuel Puig-Domingo, MD, PhD
Germans Trias I Pujol Research Institute and Hospital, Universitat Autònoma of Barcelona, Barcelona, Spain
The content is produced by Infomedica, the official reporting partner of ENDO Online 2020. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Raghu Mirmira, MD, PhD, the scientific editor of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Marie E. McDonnell, MD
Harvard Medical School, Boston, MA
About the Expert
Marie E. McDonnell, MD
Harvard Medical School, Boston, MA
Dr. McDonnell is Chief of the Diabetes Section in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital and Harvard Medical School in Boston. In her current role as Director of the Diabetes Program at Brigham Health, Dr. McDonnell provides clinical, academic, and administrative leadership of the hospital-wide diabetes program. A graduate of Boston University School of Medicine, the New York Presbyterian Hospital-Columbia residency program, and Endocrinology fellowship at Boston Medical Center, Dr. McDonnell’s clinical research focus is health outcomes of scalable specialty-level diabetes care delivery services in the acute and ambulatory settings. Dr. McDonnell teaches medical students at Harvard Medical School and is key faculty for both the Medicine and Endocrinology training programs at Brigham and Women’s Hospital. She has served on several national committees, including the Endocrine Society Guidelines committee. She has co-authored the Society of Thoracic Surgeons practice guideline on blood glucose management during adult cardiac surgery, the Endocrine Society guideline on the Pharmacologic Management of Obesity, and Endocrine Society Guideline on the Management of Diabetes in Older Adults. She is currently on the writing committee on the Endocrine Society Guideline for Management of Hyperglycemia in the Hospital Setting.
References
1. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ.2020;369:m1966.
2. Cole SA, Laviada-Molina HA, Serres-Perales JM, Rodriguez-Ayala E, Bastarrachea RA. The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins? Pathogens.2020;9(5):E389.
3. Zhu L, She ZG, Cheng X, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab.2020;31(6):1068-1077.e3.
